Monoclonal anti-cardiolipin antibodies from New Zealand Black x New Zealand White F1 mice react to thrombomodulin. 1998

K Haruta, and S Kobayashi, and S Hirose, and A Horiai, and M Ohyanagi, and M Tanaka, and T Kawano, and T Shirai, and Y Takasaki, and H Hashimoto
Research Laboratory, Zenyaku Kogyo Co. Ltd., Tokyo, Japan.

The reactivity with and affinity for thrombomodulin (TM) of monoclonal anti-cardiolipin Abs (MoaCL), derived from a New Zealand Black x New Zealand White F1 (NZB/W F1) mouse, were studied to investigate the pathogenicity of anti-cardiolipin Abs (aCL). Four of eighteen MoaCL were found to react with rabbit TM when examined using ELISA. These four MoaCL also reacted with synthetic peptide that included the epidermal growth factor-like domain of human TM, a binding site for thrombin. The reaction with TM of these four MoaCL was inhibited by bovine thrombin. When the affinity for TM of the MoaCL was determined, the dissociation constants (Kd) ranged from 4.8 x 10(-9) to 4.7 x 10(-8) M. By contrast, examination of the affinity for cardiolipin (CL) gave values from 8.3 x 10(-6) to 7.4 x 10(-5) M. Thus, these MoaCL reacted to TM with a higher affinity than to CL. Moreover, these MoaCL also bound to TM on HUVEC and down-regulated the expression level of TM on the surface of HUVEC due to internalization of TM. The binding of thrombin to TM is known to initiate rapid protein C activation, and complexes of activated protein C and protein S show anticoagulatory activity. Thus, the present studies suggest that certain pathogenic aCL cross-react with TM and induce down-regulation of TM on endothelial cells, followed by induction of thrombosis.

UI MeSH Term Description Entries
D007141 Immunoglobulin Fc Fragments Crystallizable fragments composed of the carboxy-terminal halves of both IMMUNOGLOBULIN HEAVY CHAINS linked to each other by disulfide bonds. Fc fragments contain the carboxy-terminal parts of the heavy chain constant regions that are responsible for the effector functions of an immunoglobulin (COMPLEMENT fixation, binding to the cell membrane via FC RECEPTORS, and placental transport). This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fc Fragment,Fc Fragments,Fc Immunoglobulin,Fc Immunoglobulins,Ig Fc Fragments,Immunoglobulin Fc Fragment,Immunoglobulins, Fc,Immunoglobulins, Fc Fragment,Fc Fragment Immunoglobulins,Fc Fragment, Immunoglobulin,Fc Fragments, Ig,Fc Fragments, Immunoglobulin,Fragment Immunoglobulins, Fc,Fragment, Fc,Fragments, Ig Fc,Immunoglobulin, Fc
D002308 Cardiolipins Acidic phospholipids composed of two molecules of phosphatidic acid covalently linked to a molecule of glycerol. They occur primarily in mitochondrial inner membranes and in bacterial plasma membranes. They are the main antigenic components of the Wassermann-type antigen that is used in nontreponemal SYPHILIS SERODIAGNOSIS. Cardiolipin,Diphosphatidylglycerol,Diphosphatidylglycerols
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin
D017153 Antibodies, Anticardiolipin Antiphospholipid antibodies found in association with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. The antibodies are detected by solid-phase IMMUNOASSAY employing the purified phospholipid antigen CARDIOLIPIN. Anticardiolipin Antibodies,Anticardiolipin Autoantibodies,Anticardiolipin Autoantibody,Cardiolipin Autoantibodies,Cardiolipin Autoantibody,Anticardiolipin Antibody,Antibody, Anticardiolipin,Autoantibody, Anticardiolipin,Autoantibody, Cardiolipin

Related Publications

K Haruta, and S Kobayashi, and S Hirose, and A Horiai, and M Ohyanagi, and M Tanaka, and T Kawano, and T Shirai, and Y Takasaki, and H Hashimoto
February 1986, Journal of immunology (Baltimore, Md. : 1950),
K Haruta, and S Kobayashi, and S Hirose, and A Horiai, and M Ohyanagi, and M Tanaka, and T Kawano, and T Shirai, and Y Takasaki, and H Hashimoto
September 2004, Journal of immunology (Baltimore, Md. : 1950),
K Haruta, and S Kobayashi, and S Hirose, and A Horiai, and M Ohyanagi, and M Tanaka, and T Kawano, and T Shirai, and Y Takasaki, and H Hashimoto
January 1980, Developmental and comparative immunology,
K Haruta, and S Kobayashi, and S Hirose, and A Horiai, and M Ohyanagi, and M Tanaka, and T Kawano, and T Shirai, and Y Takasaki, and H Hashimoto
July 1994, Immunology,
K Haruta, and S Kobayashi, and S Hirose, and A Horiai, and M Ohyanagi, and M Tanaka, and T Kawano, and T Shirai, and Y Takasaki, and H Hashimoto
December 1997, Journal of immunology (Baltimore, Md. : 1950),
K Haruta, and S Kobayashi, and S Hirose, and A Horiai, and M Ohyanagi, and M Tanaka, and T Kawano, and T Shirai, and Y Takasaki, and H Hashimoto
November 1984, Immunology,
K Haruta, and S Kobayashi, and S Hirose, and A Horiai, and M Ohyanagi, and M Tanaka, and T Kawano, and T Shirai, and Y Takasaki, and H Hashimoto
May 1990, Arthritis and rheumatism,
K Haruta, and S Kobayashi, and S Hirose, and A Horiai, and M Ohyanagi, and M Tanaka, and T Kawano, and T Shirai, and Y Takasaki, and H Hashimoto
October 1988, Clinical and experimental immunology,
K Haruta, and S Kobayashi, and S Hirose, and A Horiai, and M Ohyanagi, and M Tanaka, and T Kawano, and T Shirai, and Y Takasaki, and H Hashimoto
December 1998, Journal of immunology (Baltimore, Md. : 1950),
K Haruta, and S Kobayashi, and S Hirose, and A Horiai, and M Ohyanagi, and M Tanaka, and T Kawano, and T Shirai, and Y Takasaki, and H Hashimoto
May 1987, Arthritis and rheumatism,
Copied contents to your clipboard!